Malaysia · Delayed Price · Currency is MYR KLSE:SUNMED Statistics
Total Valuation
KLSE:SUNMED has a market cap or net worth of MYR 21.05 billion. The enterprise value is 21.44 billion.
| Market Cap | 21.05B |
| Enterprise Value | 21.44B |
Important Dates
The next estimated earnings date is Wednesday, August 19, 2026.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KLSE:SUNMED has 11.50 billion shares outstanding. The number of shares has increased by 5.27% in one year.
| Current Share Class | 11.50B |
| Shares Outstanding | 11.50B |
| Shares Change (YoY) | +5.27% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 7.02% |
| Float | 2.51B |
Valuation Ratios
The trailing PE ratio is 85.52 and the forward PE ratio is 59.22. KLSE:SUNMED's PEG ratio is 2.71.
| PE Ratio | 85.52 |
| Forward PE | 59.22 |
| PS Ratio | 9.10 |
| PB Ratio | 6.44 |
| P/TBV Ratio | 6.51 |
| P/FCF Ratio | 748.04 |
| P/OCF Ratio | 45.90 |
| PEG Ratio | 2.71 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 42.51, with an EV/FCF ratio of 762.13.
| EV / Earnings | 86.88 |
| EV / Sales | 9.27 |
| EV / EBITDA | 42.51 |
| EV / EBIT | 71.11 |
| EV / FCF | 762.13 |
Financial Position
The company has a current ratio of 1.93, with a Debt / Equity ratio of 0.49.
| Current Ratio | 1.93 |
| Quick Ratio | 1.81 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 3.20 |
| Debt / FCF | 57.44 |
| Interest Coverage | 4.67 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.61% |
| Return on Capital Employed (ROCE) | 6.48% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, KLSE:SUNMED has paid 24.36 million in taxes.
| Income Tax | 24.36M |
| Effective Tax Rate | 8.98% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1.83 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 52.55 |
| Average Volume (20 Days) | 14,472,735 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:SUNMED had revenue of MYR 2.31 billion and earned 246.79 million in profits. Earnings per share was 0.02.
| Revenue | 2.31B |
| Gross Profit | 1.44B |
| Operating Income | 301.54M |
| Pretax Income | 271.16M |
| Net Income | 246.79M |
| EBITDA | 494.17M |
| EBIT | 301.54M |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 1.22 billion in cash and 1.62 billion in debt, with a net cash position of -396.56 million or -0.03 per share.
| Cash & Cash Equivalents | 1.22B |
| Total Debt | 1.62B |
| Net Cash | -396.56M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 3.27B |
| Book Value Per Share | 0.28 |
| Working Capital | 853.76M |
Cash Flow
In the last 12 months, operating cash flow was 458.51 million and capital expenditures -430.38 million, giving a free cash flow of 28.13 million.
| Operating Cash Flow | 458.51M |
| Capital Expenditures | -430.38M |
| Depreciation & Amortization | 192.63M |
| Net Borrowing | 841.03M |
| Free Cash Flow | 28.13M |
| FCF Per Share | 0.00 |
Margins
Gross margin is 62.24%, with operating and profit margins of 13.03% and 10.67%.
| Gross Margin | 62.24% |
| Operating Margin | 13.03% |
| Pretax Margin | 11.72% |
| Profit Margin | 10.67% |
| EBITDA Margin | 21.36% |
| EBIT Margin | 13.03% |
| FCF Margin | 1.22% |
Dividends & Yields
KLSE:SUNMED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 294.88% |
| Buyback Yield | -5.27% |
| Shareholder Yield | -5.27% |
| Earnings Yield | 1.17% |
| FCF Yield | 0.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for KLSE:SUNMED is 1.86, which is 1.64% higher than the current price. The consensus rating is "Buy".
| Price Target | 1.86 |
| Price Target Difference | 1.64% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 17.42% |
| EPS Growth Forecast (3Y) | 22.87% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |